Septerna (SEPN) Raises $302.6 Million in IPO to Fuel Drug Development Pipeline
Septerna Inc. (SEPN) is a clinical-stage biotechnology company revolutionizing drug discovery through its proprietary Native Complex Platform™, which…
Browsing Tag